Brief: Cycle Pharmaceuticals gets FDA approval for Ketorolac Tromethamine injection
19/09/2017 14:30
Sept 19 (Reuters) - Cycle Pharmaceuticals:
* Cycle Pharmaceuticals receives FDA approval and launches
Ketorolac Tromethamine injection 30mg/ml in the U.S.
* Cycle Pharmaceuticals receives FDA approval and launches
Ketorolac Tromethamine injection 30mg/ml in the U.S.
Source text for Eikon: ID:nBw27vNHWa
((Bangalore.newsroom@thomsonreuters.com;;))
Recent news on Caplin Point Laboratories
See all newsBrief: Caplin Point Laboratories Says US FDA Completes Unannounced Inspection Of Caplin Steriles Gummidipoondi Facility
Brief: Caplin Point Laboratories March-Quarter Consol Net Profit 1.7 Bln Rupees
Brief: Caplin Point Laboratories Unit Receives Final USFDA Approval For ANDA Potassium Phosphates Injection
Brief: Caplin Point Laboratories Says Unit Receives USFDA Approval For Sodium Phosphates Injection
Brief: Caplin Point Laboratories Dec-Quarter Consol Net Profit 1.64 Billion Rupees